| Previous Close | 63.00 |
| Open | 62.91 |
| Bid | 63.14 x 1000 |
| Ask | 63.20 x 300 |
| Day's Range | 62.80 - 63.18 |
| 52 Week Range | 53.55 - 69.24 |
| Volume | 9,448 |
| Avg. Volume | 57,004 |
| Net Assets | 746.95M |
| NAV | 62.77 |
| PE Ratio (TTM) | -5.26 |
| Yield | 0.81% |
| YTD Return | 12.39% |
| Beta (3y) | 1.01 |
| Expense Ratio (net) | 0.56% |
| Inception Date | 2005-06-23 |
- Market Realist•4 hours ago
Behind Pfizer’s Legacy Established Products Performance in 2017
In 2016, Pfizer’s (PFE) Lipitor reported revenues of ~$1.8 billion, which represented a ~5% YoY (year-over-year) fall.
- Market Realist•14 days ago
Behind Allergan’s Business Segments and Revenues
Allergan's (AGN) business has undergone several changes over the past few years due to acquisitions and divestitures.
- Zacks•18 days ago
What Lies Ahead for Pharma ETFs in Second Half 2017
We discuss some of the factors that could contribute to a sustained recovery in the sector.
